Retraction

Lentivirus-Mediated Knockdown of Myosin VI Inhibits Cell Proliferation of Breast Cancer Cell

Retraction Details

Citations (26)

26
Total Citations
8
Post-Retraction
(30.8%)
18
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
3 Within 30 days
6 Within 1 year
1 After 2+ years
1120 Days since retraction (latest)
MYO6 contributes to tumor progression and enzalutamide resistance in castration-resistant prostate cancer by activating the focal adhesion signaling pathway
Shengfeng Zheng, Zhe Hong, Yao Tan et al. (10 authors)
Cell Communication and Signaling Open Access
Published: Oct 2024
1 citation
1120 days after retraction
A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia
Luca Menin, Janine Weber, Stefano Villa et al. (17 authors)
Cell Reports Open Access
Published: Aug 2023
1 citation
670 days after retraction
Binding partners regulate unfolding of myosin VI to activate the molecular motor
Ália dos Santos, Natalia Fili, Yukti Hari‐Gupta et al. (10 authors)
Biochemical Journal Open Access
Published: Jun 2022
11 citations
263 days after retraction
The Study of Disease Mechanisms Based on Cascading Failure
Dandan Zhang, Yanhui Wang
Unknown Journal
Published: May 2022
225 days after retraction
Comparison of co-immunoprecipitation techniques for effective identification of SNTA1 interacting proteins in breast cancer cells
Saima Sajood, Thottethodi Subrahmanya Keshava Prasad, Basharat Bhat et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Mar 2022
1 citation
169 days after retraction
<b><i>Retraction of:</i></b> Ribosomal Protein S15A Augments Human Osteosarcoma Cell Proliferation <i>In Vitro</i> (doi: 10.1089/cbr.2014.1698)
Unknown Authors
Cancer Biotherapy and Radiopharmaceuticals Open Access
Published: Oct 2021
1 days after retraction
<b><i>Retraction of:</i></b> Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer (doi: 10.1089/cbr.2014.1778)
Unknown Authors
Cancer Biotherapy and Radiopharmaceuticals
Published: Oct 2021
1 days after retraction
Dynein and muskelin control myosin VI delivery towards the neuronal nucleus
Matthias Kneussel, Noelia Sánchez-Rodríguez, Michaela Mischak et al. (4 authors)
iScience Open Access
Published: Apr 2021
6 citations
174 days before retraction
Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism
Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Iekhsan Othman et al. (4 authors)
Cancers Open Access
Published: Aug 2020
24 citations
395 days before retraction
The Expressions and Mechanisms of Sarcomeric Proteins in Cancers
Xiaojing Yang, Hanru Ren, Xiaomao Guo et al. (5 authors)
Disease Markers Open Access
Published: Jun 2020
9 citations
457 days before retraction
Binding partners regulate unfolding of myosin VI to activate the molecular motor
Ália dos Santos, Natalia Fili, Yukti Hari‐Gupta et al. (10 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: May 2020
4 citations
508 days before retraction
Nuclear myosin VI regulates the spatial organization of mammalian transcription initiation
Yukti Hari‐Gupta, Natalia Fili, Ália dos Santos et al. (16 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Apr 2020
14 citations
526 days before retraction
Long noncoding RNA <i>UCA1</i> promotes cell growth, migration, and invasion by targeting miR‐143‐3p in oral squamous cell carcinoma
Qingyun Duan, Mei Xu, Meng Wu et al. (6 authors)
Cancer Medicine Open Access
Published: Mar 2020
30 citations
575 days before retraction
&lt;p&gt;HNF1A-AS1 Regulates Cell Migration, Invasion and Glycolysis via Modulating miR-124/MYO6 in Colorectal Cancer Cells&lt;/p&gt;
Xiong Guo, Yang Zhang, Ling Liu et al. (5 authors)
OncoTargets and Therapy Open Access
Published: Feb 2020
35 citations
607 days before retraction
Myosins: Driving us towards novel targets and biomarkers in cancer
Eric Koncina, Elisabeth Letellier
International review of cell and molecular biology
Published: Jan 2020
2 citations
638 days before retraction
Myosins and Disease
Lynne M. Coluccio
Advances in experimental medicine and biology
Published: Jan 2020
26 citations
638 days before retraction
MicroRNA-5195-3p plays a suppressive role in cell proliferation, migration and invasion by targeting MYO6 in human non-small cell lung cancer
Quanfu Yang
Bioscience Biotechnology and Biochemistry Open Access
Published: Nov 2018
24 citations
1063 days before retraction
Profiling plasma extracellular vesicle by pluronic block‐copolymer based enrichment method unveils features associated with breast cancer aggression, metastasis and invasion
Zhenyu Zhong, Matthew Rosenow, Nick Xiao et al. (4 authors)
Journal of Extracellular Vesicles Open Access
Published: Apr 2018
24 citations
1274 days before retraction
BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells
Chandan Kanta Das, Benedikt Linder, Florian Bonn et al. (9 authors)
Neoplasia Open Access
Published: Feb 2018
87 citations
1316 days before retraction
NDP52 activates nuclear myosin VI to enhance RNA polymerase II transcription
Natalia Fili, Yukti Hari‐Gupta, Ália dos Santos et al. (8 authors)
Nature Communications Open Access
Published: Nov 2017
59 citations
1406 days before retraction
miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6
Chao Lei, Feng Du, Lina Sun et al. (13 authors)
Cell Death and Disease Open Access
Published: Oct 2017
134 citations
1449 days before retraction
DNA/RNA-based formulations for treatment of breast cancer
Zhaolu Xie, Xianghui Zeng
Expert Opinion on Drug Delivery
Published: Apr 2017
10 citations
1636 days before retraction
How myosin organization of the actin cytoskeleton contributes to the cancer phenotype
Michelle Peckham
Biochemical Society Transactions Open Access
Published: Aug 2016
36 citations
1872 days before retraction
Overexpression of myosin VI regulates gastric cancer cell progression
Zishu Wang, Mingzhen Ying, Qiong Wu et al. (5 authors)
Gene Open Access
Published: Aug 2016
17 citations
1877 days before retraction
MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40
Dong Wang, Libing Zhu, Min Liao et al. (7 authors)
Oncology Reports Open Access
Published: Jun 2016
31 citations
1919 days before retraction
Quick Stats
Total Citations: 26
Years Since Retraction: 4.1 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Mortal Obligate RNA Transcript Inhibits Cancer Cell Invasio…
Cancer Biotherapy & Radiopharmaceuticals • 10 citations
Long Noncoding RNA CTD-2589M5.4 Inhibits Ovarian Cancer Cel…
Cancer Biotherapy & Radiopharmaceuticals • 11 citations
CircSMARCA5 Facilitates the Progression of Prostate Cancer …
Cancer Biotherapy & Radiopharmaceuticals • 31 citations
Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regu…
Cancer Biotherapy & Radiopharmaceuticals • 25 citations
PHOX2B Is Associated with Neuroblastoma Cell Differentiation
Cancer Biotherapy & Radiopharmaceuticals • 11 citations